This week PharmaShots’ news was all about the updates on Clinical Trials, Pharma, Biotech, COVID-19, Regulatory & MedTech. Check out our full report below:

AstraZeneca Provides Update on P-III (AMPLIFY) Trial of Calquence for Treating Chronic Lymphocytic Leukemia

Read More: Astrazeneca                                                                       

BioNTech Reports Topline Data from P-II Study of BNT111 to Treat Advanced Melanoma Patients

Read More: BioNTech                                                                                

ALX Oncology Provides Update on P-II (ASPEN-06) Study of Evorpacept to Treat Gastric Cancer

Read More: ALX Oncology                                                                                           

Eli Lilly Reports the P-III (SUMMIT) Trial Data of Tirzepatide to Treat Heart Failure with Preserved Ejection Fraction and Obesity

Read More: Eli Lilly                                                                                              

Merck and Daiichi Sankyo Report the Initiation of P-III (IDeate-Lung02) Study of Ifinatamab Deruxtecan to Treat Small Cell Lung Cancer

Read More: Merck & Daiichi Sankyo                                                        

Astellas Reports the CHMP’s Positive Opinion of Zolbetuximab to Treat Gastric and Gastroesophageal Junction Cancer

Read More: Astellas                                                                                                       

CStone Pharmaceuticals’s Cejemly (Sugemalimab) Receives the EC’s Approval to Treat Non-Small Cell Lung Cancer

Read More: CStone Pharmaceuticals                                                                        

Junshi Biosciences Reports the CHMP’s Positive Opinion of Loqtorzi (Toripalimab) Across Two Indications

Read More: Junshi Biosciences                                                                            

Roche’s Vabysmo (Faricimab) Receives the EC’s Approval to Treat Retinal Vein Occlusion (RVO)

Read More: Roche                                                                                                       

Verastem Oncology’s Avutometinib Gains the US FDA’s Orphan Drug Designation to Treat Pancreatic Cancer

Read More: Verastem Oncology                                                                              

Johnson & Johnson’s Darzalex Faspro Quadruplet Combination Gains the US FDA’s Approval to Treat Multiple Myeloma (MM)

Read More: Johnson & Johnson                                                                              

Innovent Reports the NMPA’s NDA Acceptance of Mazdutide to Treat Type 2 Diabetes

Read More: Innovent                                                                                             

GSK Reports the US FDA’s Expanded Approval of Jemperli Plus Chemotherapy for Treating Endometrial Cancer

Read More: GSK                                                                                                  

Bayer Submits NDA of Elinzanetant, Seeking Approval in the US for Vasomotor Symptoms Treatment

Read More: Bayer                                                                                              

Fresenius Kabi and Formycon Report the CHMP’s Positive Opinion of FYB202 (Biosimilar, Stelara)

Read More: Fresenius Kabi & Formycon                                                           

Prestige Biopharma Reports the CHMP’s Positive Opinion of Tuznue (Biosimilar, Herceptin)

Read More: Prestige Biopharma                                                                           

Bio-Thera Reports the EMA’s Approval of Avzivi (Biosimilar, Avastin) for Treating Multiple Indications

Read More: Bio-Thera                                                                                          

Xbrane Biopharma Reclaims Rights of BIIB801 (Biosimilar, Cimzia) from Biogen

Read More: Xbrane Biopharma                                                                        

Celltrion’s Steqeyma (Biosimilar, Stelara) Receives the Health Canada’s Approval to Treat Various Chronic Inflammatory Conditions

Read More: Celltrion                                                                                                 

Mankind Pharma Acquires Bharat Serums and Vaccines for $1.64B

Read More: Mankind Pharma & Bharat Serums and Vaccines                     

Boehringer Ingelheim Reports the Acquisition of Nerio Therapeutics for $1.3B

Read More: Boehringer Ingelheim & Nerio Therapeutics                               

Otsuka Pharmaceutical to Acquire Jnana Therapeutics, Expanding its Autoimmune Portfolio and Drug Discovery Technologies

Read More: Otsuka Pharmaceutical & Jnana Therapeutics                      

GSK and Flagship Pioneering Join Forces to Discover Novel Therapeutics and Vaccines

Read More: GSK & Flagship Pioneering                                  

IDEAYA Biosciences Collaborates with Biocytogen to Develop Bispecific ADC Program for Cancer Treatment

Read More: IDEAYA Biosciences & Biocytogen                                             

Valneva and LimmaTech Biologics Join Forces to Develop Shigella4V Against Shigellosis

Read More: Valneva & LimmaTech Biologics                                                    

BostonGene and Takeda Collaborate to Investigate Immunotherapies through Molecular Profiling

Read More: BostonGene & Takeda                                                           

Thermo Fisher Scientific Reports the US FDA’s Extended Approval of Freelite Assays for Multiple Myeloma

Read More: Thermo Fisher Scientific                                                                  

Life Spine Reports the US FDA’s Approval of the ARx SAI Spinal Fixation System

Read More: Life Spine                                                                                               

Protect Animal Health and DotBio Join Forces to Develop Therapies and Technologies for Companion Animals

Read More: Protect Animal Health & DotBio                                                       

ELIAS Animal Health to Initate Clinical Evaluation of T-Cell Therapy for Limb-Sparing Canine Osteosarcoma

Read More: ELIAS Animal Health                            

Related Post: PharmaShots Weekly Snapshots (July 22 – July 26, 2024)